Sprint Bioscience AB (publ) (STO:SPRINT)

ShockWave Medical Revenue

Sprint Bioscience AB had revenue of 14.11M SEK in the quarter ending March 31, 2025, a decrease of -21.05%. This brings the company's revenue in the last twelve months to 62.38M, down -10.32% year-over-year. In the year 2024, Sprint Bioscience AB had annual revenue of 66.14M with 27.97% growth.

• Revenue (ttm): 62.38M
• Revenue Growth: -10.32%
• P/S Ratio: 0.92
• Revenue / Employee: 1.64M
• Employees: 38
• Market Cap: 57.19M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	66.14M	14.46M	27.97%
Dec 31, 2023	51.69M	51.60M	62,171.08%
Dec 31, 2022	83.00K	-34.95M	-99.76%
Dec 31, 2021	35.03M	15.83M	82.49%
Dec 31, 2020	19.20M	-14.62M	-43.23%